Drugs / CP1050
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03468413 | Feb → Aug 2018 | — | Curadim Pharma Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CP1050 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03468413 ↗ |
| Route | Oral | “single and multiple oral dose study” NCT03468413 ↗ |